Abstract
Purpose of Review
Obesity and its related comorbidities make up a large part of healthcare expenditures. Despite a wide array of options for treatment of obesity, rates of sustained weight loss continue to be low, leading patients to seek alternative treatment options. Although the first medically utilized ketogenic diet was described nearly 100 years ago, it has made a resurgence as a treatment option for obesity. Despite increased popularity in the lay public and increased use of ketogenic dietary strategies for metabolic therapy, we are still beginning to unravel the metabolic impact of long-term dietary ketosis.
Recent Findings
There are a number of recent trials that have highlighted the short- and long-term benefits of ketogenic diet on weight, glycemic control, and other endocrine functions including reproductive hormones.
Summary
This review is a summary of available data on the effectiveness and durability of the ketogenic diet when compared to conventional interventions. Ketogenic dietary strategies may play a role in short-term improvement of important metabolic parameters with potential for long-term benefit. However, response may vary due to inter-individual ability to maintain long-term carbohydrate restriction.
This is a preview of subscription content, access via your institution.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Biener, A., J. Cawley, and C. Meyerhoefer, The high and rising costs of obesity to the US health care system. 2017, Springer.
Ng M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–81.
•• Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27 (A global study showing the impact of obesity in the last 2 decades, reported a two fold increase in obesity from the 1980s).
Flegal KM, et al. Trends in Obesity Among Adults in the United States, 2005 to 2014. Jama. 2016;315(21):2284–91.
Bray MS, et al. NIH working group report-using genomic information to guide weight management: from universal to precision treatment. Obesity (Silver Spring). 2016;24(1):14–22.
van der Klaauw AA, Farooqi IS. The hunger genes: pathways to obesity. Cell. 2015;161(1):119–32.
Church TS, et al. Trends over 5 decades in U.S. occupation-related physical activity and their associations with obesity. PLoS One. 2011;6(5):e19657.
McAllister EJ, et al. Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr. 2009;49(10):868–913.
Tchkonia T, et al. Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab. 2013;17(5):644–56.
Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860.
Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376(3):254–66.
Ryan DH. Guidelines for obesity management. Endocrinol Metab Clin N Am. 2016;45(3):501–10.
Velapati SR, et al. Weight regain after bariatric surgery: prevalence, etiology, and treatment. Curr Nutr Rep. 2018;7(4):329–34.
Wheless JW. History of the ketogenic diet. Epilepsia. 2008;49(Suppl 8):3–5.
Wilder RM, Winter MD. The threshold of ketogenesis. J Biol Chem. 1922;52(2):393–401.
HELMHOLZ HF. The treatment of epilepsy in childhood: five years’ experience with the ketogenic diet. JAMA. 1927;88(26):2028–32.
Peterman M. The ketogenic diet in epilepsy. J Am Med Assoc. 1925;84(26):1979–83.
Westman EC, Yancy WS, Humphreys M. Dietary treatment of diabetes mellitus in the pre-insulin era (1914-1922). Perspect Biol Med. 2006;49(1):77–83 https://muse.jhu.edu/ (accessed June 30, 2019).
Atkins RD. Dr. Government Institutes: Atkins’ new diet revolution; 2002.
Feinman RD, et al. Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. Nutrition. 2015;31(1):1–13.
Kossoff EH, Dorward JL. The modified Atkins diet. Epilepsia. 2008;49(Suppl 8):37–41.
Westman EC, et al. Low-carbohydrate nutrition and metabolism. Am J Clin Nutr. 2007;86(2):276–84.
Veech RL. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fat Acids. 2004;70(3):309–19.
Thomsen HH, et al. Effects of 3-hydroxybutyrate and free fatty acids on muscle protein kinetics and signaling during LPS-induced inflammation in humans: anticatabolic impact of ketone bodies. Am J Clin Nutr. 2018;108(4):857–67.
Koppel SJ, Swerdlow RH. Neuroketotherapeutics: a modern review of a century-old therapy. Neurochem Int. 2018;117:114–25.
Crawford P. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Biophys J. 2019;116(3, Supplement 1):2a.
Ma D, et al. Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice. Sci Rep. 2018;8(1):6670.
Kuchkuntla AR, et al. Fad diets: hype or hope? Curr Nutr Rep. 2018;7(4):310–23.
Newsholme EA, Dimitriadis G. Integration of biochemical and physiologic effects of insulin on glucose metabolism. Exp Clin Endocrinol Diabetes. 2001;109(Suppl 2):S122–34.
Plum L, Belgardt BF, Brüning JC. Central insulin action in energy and glucose homeostasis. J Clin Invest. 2006;116(7):1761–6.
Taborsky GJ Jr. The physiology of glucagon. SAGE Publications. 2010;4(6):1338–44.
Xiong J. Fatty acid oxidation in cell fate determination. Trends Biochem Sci. 2018;43(11):854–7.
Rui L. Energy metabolism in the liver. Compr Physiol. 2011;4(1):177–97.
Cahill G, et al. Hormone-fuel interrelationships during fasting. J Clin Invest. 1966;45(11):1751–69.
VanItallie TB, Nufert TH. Ketones: metabolism’s ugly duckling. Nutr Rev. 2003;61(10):327–41.
Gupta L, et al. Ketogenic diet in endocrine disorders: current perspectives. J Postgrad Med. 2017;63(4):242–51.
Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev. 1999;15(6):412–26.
Reichard G, et al. Ketone-body production and oxidation in fasting obese humans. J Clin Invest. 1974;53(2):508–15.
Owen OE, et al. Comparative measurements of glucose, beta-hydroxybutyrate, acetoacetate, and insulin in blood and cerebrospinal fluid during starvation. Metabolism. 1974;23(1):7–14.
Atkins RC, D.A.D. Revolution. The high calorie way to stay thin forever. New York: McKay Co.; 1972.
Atkins, R.C., Dr. Atkins’ diet revolution. 1981: Bantam Books New York.
Heinbecker P. Studies on the metabolism. J Biol Chem. 1928;80:461–75.
Jungas RL, Halperin ML, Brosnan JT. Quantitative analysis of amino acid oxidation and related gluconeogenesis in humans. Physiol Rev. 1992;72(2):419–48.
Volek JS, et al. Body composition and hormonal responses to a carbohydrate-restricted diet. Metab-Clin Exp. 2002;51(7):864–70.
Ludwig DS, Friedman MI. Increasing adiposity: consequence or cause of overeating? Jama. 2014;311(21):2167–8.
Kabir M, et al. A high glycemic index starch diet affects lipid storage–related enzymes in normal and to a lesser extent in diabetic rats. J Nutr. 1998;128(11):1878–83.
Hall KD. A review of the carbohydrate-insulin model of obesity. Eur J Clin Nutr. 2017;71(3):323–6.
Howell S, Kones R. “Calories in, calories out” and macronutrient intake: the hope, hype, and science of calories. Am J Physiol Endocrinol Metab. 2017;313(5):E608–e612.
Klein S, Wolfe RR. Carbohydrate restriction regulates the adaptive response to fasting. Am J Phys. 1992;262(5 Pt 1):E631–6.
Cox PJ, et al. Nutritional ketosis alters fuel preference and thereby endurance performance in athletes. Cell Metab. 2016;24(2):256–68.
Goedecke JH, et al. Metabolic adaptations to a high-fat diet in endurance cyclists. Metabolism. 1999;48(12):1509–17.
Westman EC, et al. A review of low-carbohydrate ketogenic diets. Curr Atheroscler Rep. 2003;5(6):476–83.
Kuchkuntla AR, et al. Fad diets: hype or hope? Current nutrition reports. 2018;7(4):310–23.
Ebbeling CB, et al. Effects of dietary composition on energy expenditure during weight-loss maintenance. Jama. 2012;307(24):2627–34.
Hall KD, et al. Energy expenditure and body composition changes after an isocaloric ketogenic diet in overweight and obese men, 2. Am J Clin Nutr. 2016;104(2):324–33.
•• Ebbeling CB, et al. Effects of a low carbohydrate diet on energy expenditure during weight loss maintenance: randomized trial. BMJ. 2018;363:k4583 (An important study evaluating the physiological changes with weight loss on Ketogenic diet focussing on energy expenditure).
Cheatham B, Kahn CR. Insulin action and the insulin signaling network*. Endocr Rev. 1995;16(2):117–42.
Smith U, et al. Insulin signaling and action in fat cells: associations with insulin resistance and type 2 diabetes. Ann N Y Acad Sci. 1999;892(1):119–26.
Kelley DE, et al. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. J Clin Invest. 1996;97(12):2705–13.
Rothman DL, et al. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci. 1995;92(4):983–7.
Shulman GI, et al. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med. 1990;322(4):223–8.
Yang Q, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005;436(7049):356.
Perseghin G, et al. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes. 1999;48(8):1600–6.
Roden M, et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest. 1996;97(12):2859–65.
Carey DG, et al. Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes. 1996;45(5):633–8.
Jung U, Choi M-S. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15(4):6184–223.
•• Volek JS, et al. Body composition and hormonal responses to a carbohydrate-restricted diet. Metabolism. 2002;51(7):864–70 (A key study that evaluated the effects of KD on endocrine changes).
Krauss RM, et al. Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. Am J Clin Nutr. 2006;83(5):1025–31 quiz 1205.
Hu T, et al. Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol. 2012;176(Suppl 7):S44–54.
•• Samaha FF, et al. A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med. 2003;348(21):2074–81 (One of the earliest RCTs comparing the KD vs Low fat diet, showing the weight loss potential of KD).
•• Dansinger ML, et al. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA. 2005;293(1):43–53 (A key landmark study comparing the metabolic effects and weight loss potentials of different diets).
•• Shai I, et al. Weight loss with a low-carbohydrate, mediterranean, or low-fat diet. N Engl J Med. 2008;359(3):229–41 (One of the long term RCTs comparing the effectiveness of different diets and their implications into clinical practice).
Abbasi J. Interest in the ketogenic diet grows for weight loss and type 2 diabetes. Jama. 2018;319(3):215–7.
Westman EC, et al. The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutr Metab. 2008;5(1):36.
Hussain TA, et al. Effect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes. Nutrition. 2012;28(10):1016–21.
Yancy WS, et al. A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutr Metab. 2005;2(1):34.
•• Meng Y, et al. Efficacy of low carbohydrate diet for type 2 diabetes mellitus management: a systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract. 2017;131:124–31 (Systematic review of 7 RCTs evaluating the effectiveness of KD in T2DM).
Huntriss R, Campbell M, Bedwell C. The interpretation and effect of a low-carbohydrate diet in the management of type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials. Eur J Clin Nutr. 2018;72(3):311–25.
•• Davis NJ, et al. Comparative study of the effects of a 1-year dietary intervention of a low-carbohydrate diet versus a low-fat diet on weight and glycemic control in type 2 diabetes. Diabetes Care. 2009;32(7):1147–52 (An important RCT showing the short-term benefits of KD in glycemic control).
Guldbrand H, et al. In type 2 diabetes, randomisation to advice to follow a low-carbohydrate diet transiently improves glycaemic control compared with advice to follow a low-fat diet producing a similar weight loss. Diabetologia. 2012;55(8):2118–27.
Oyabu C, et al. Impact of low-carbohydrate diet on renal function: a meta-analysis of over 1000 individuals from nine randomised controlled trials. Br J Nutr. 2016;116(4):632–8.
Bonikowska K, Magnusson P, Sjoholm A. Life-threatening ketoacidosis in patients with type 2 diabetes on LCHF diet. Lakartidningen. 2018;115:E4AD.
Clifton PM, Condo D, Keogh JB. Long term weight maintenance after advice to consume low carbohydrate, higher protein diets--a systematic review and meta analysis. Nutr Metab Cardiovasc Dis. 2014;24(3):224–35.
Sim KA, et al. Weight loss improves reproductive outcomes in obese women undergoing fertility treatment: a randomized controlled trial. Clin Obes. 2014;4(2):61–8.
Sim KA, Partridge SR, Sainsbury A. Does weight loss in overweight or obese women improve fertility treatment outcomes? A systematic review. Obes Rev. 2014;15(10):839–50.
McGrice M, Porter J. The effect of low carbohydrate diets on fertility hormones and outcomes in overweight and obese women: a systematic review. Nutrients. 2017;9(3):204.
Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352(12):1223–36.
Moran LJ, et al. Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines. J Acad Nutr Diet. 2013;113(4):520–45.
Mavropoulos JC, et al. The effects of a low-carbohydrate, ketogenic diet on the polycystic ovary syndrome: a pilot study. Nutr Metab. 2005;2(1):35.
Volek JS, et al. Metabolic characteristics of keto-adapted ultra-endurance runners. Metabolism. 2016;65(3):100–10.
Urbain P, et al. Impact of a 6-week non-energy-restricted ketogenic diet on physical fitness, body composition and biochemical parameters in healthy adults. Nutr Metab. 2017;14(1):17.
Paoli A, et al. Ketogenic diet does not affect strength performance in elite artistic gymnasts. J Int Soc Sports Nutr. 2012;9(1):34.
Wilson JM, et al., The effects of ketogenic dieting on body composition, strength, power, and hormonal profiles in resistance training males. J Strength Cond Res, 2017.
Santos HO. Ketogenic diet and testosterone increase: is the increased cholesterol intake responsible? To what extent and under what circumstances can there be benefits? Hormones (Athens). 2017;16(3):266–70.
Kopp W. Nutrition, evolution and thyroid hormone levels - a link to iodine deficiency disorders? Med Hypotheses. 2004;62(6):871–5.
Pasquali R, et al. Relationships between iodothyronine peripheral metabolism and ketone bodies during hypocaloric dietary manipulations. J Endocrinol Investig. 1983;6(2):81–9.
Reinhardt W, et al. Effect of small doses of iodine on thyroid function during caloric restriction in normal subjects. Horm Res. 1993;39(3-4):132–7.
Serog P, et al. Effects of slimming and composition of diets on VO2 and thyroid hormones in healthy subjects. Am J Clin Nutr. 1982;35(1):24–35.
•• Kose E, et al. Changes of thyroid hormonal status in patients receiving ketogenic diet due to intractable epilepsy. J Pediatr Endocrinol Metab. 2017;30(4):411–6 (Pediatric study that has reported a risk of hypothyroidism with long-term use of KD).
Iacovides S, Meiring RM. The effect of a ketogenic diet versus a high-carbohydrate, low-fat diet on sleep, cognition, thyroid function, and cardiovascular health independent of weight loss: study protocol for a randomized controlled trial. Trials. 2018;19(1):62.
Author information
Authors and Affiliations
Contributions
Manpreet Mundi and Ryan Hurt formulated an outline of the manuscript. Aravind Kuchkuntla created the first draft. Manpreet Mundi, Meera Shah, Aravind Kuchkuntla, Saketh Velapati, Victoria Gershuni, Tamim Rajjo, Sanjeev Nanda, and Ryan Hurt critically revised the manuscript. All authors agree to be responsible for its content.
Corresponding author
Ethics declarations
Conflict of Interest
Aravind Reddy Kuchkuntla declares that he has no conflict of interest.
Meera Shah declares that she has no conflict of interest.
Saketh Velapati declares that he has no conflict of interest.
Victoria M. Gershuni declares that she has no conflict of interest.
Tamim Rajjo declares that he has no conflict of interest.
Sanjeev Nanda declares that he has no conflict of interest.
Ryan T. Hurt has served as a consultant for Nestlé.
Manpreet S. Mundi has received research funding from Fresenius Kabi, Nestlé, and Real Food Blends.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kuchkuntla, A.R., Shah, M., Velapati, S. et al. Ketogenic Diet: an Endocrinologist Perspective. Curr Nutr Rep 8, 402–410 (2019). https://doi.org/10.1007/s13668-019-00297-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13668-019-00297-x
Keywords
- Obesity
- Diabetes
- Ketogenic diet
- Weight loss